Concepedia

Author

Julien Boudreault

McGill University Health Centre

Also Known As

Julien Boudreault

33

Publications

386

Citations

11

H-Index

9

Concepts

All Affiliations

McGill University Health CentreMcGill UniversityUniversity of Sharjah
JB

About

Julien Boudreault is an author at McGill University Health Centre specializing in natural sciences, structural biology, and chemical biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

27

2

Natural Sciences

1

1

27

3

Biochemistry

1

1

27

4

Chemical Biology

1

1

27

5

Molecular Biology

1

1

27

Julien Boudreault

×

11

Publications

371

Citations

11

H-Index

YearCitations

In vivo genome-wide CRISPR screen reveals breast cancer vulnerabilities and synergistic mTOR/Hippo targeted combination therapy

Meiou Dai, Gang Yan, Ni Wang,

Nature Communications

2021

129

Differential Regulation of Cancer Progression by CDK4/6 Plays a Central Role in DNA Replication and Repair Pathways

Meiou Dai, Julien Boudreault, Ni Wang,

Cancer Research

2020

50

Transforming Growth Factor-beta Regulation of Ephrin Type-A Receptor 4 Signaling in Breast Cancer Cellular Migration

Ibrahim Y. Hachim, Manuel Villatoro, Lucie Canaff,

Scientific Reports

2017

37

Unprecedented tunability of riboswitch structure and regulatory function by sub-millimolar variations in physiological Mg2+

Kaley McCluskey, Julien Boudreault, Patrick St-Pierre,

Nucleic Acids Research

2019

27

Identification of MFGE8 and KLK5/7 as mediators of breast tumorigenesis and resistance to COX-2 inhibition

Jun Tian, Vivian Wang, Ni Wang,

Breast Cancer Research

2021

26

TGFβ/cyclin D1/Smad-mediated inhibition of BMP4 promotes breast cancer stem cell self-renewal activity

Gang Yan, Meiou Dai, Chenjing Zhang,

Oncogenesis

2021

22

Prolactin receptor-driven combined luminal and epithelial differentiation in breast cancer restricts plasticity, stemness, tumorigenesis and metastasis

Anwar Shams, Najat Binothman, Julien Boudreault,

Oncogenesis

2021

21

Genome-wide in vivo CRISPR screen identifies TGFβ3 as actionable biomarker of palbociclib resistance in triple negative breast cancer

Sophie Poulet, Meiou Dai, Ni Wang,

Molecular Cancer

2024

18

Combined in vitro/in vivo genome-wide CRISPR screens in triple negative breast cancer identify cancer stemness regulators in paclitaxel resistance

Gang Yan, Meiou Dai, Sophie Poulet,

Oncogenesis

2023

15

Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs

Amina Jamal Laham, Raafat El‐Awady, Maha Saber-Ayad,

npj Precision Oncology

2024

14

Page 1